Jerash Holdings (US), Inc. JRSH 深 滬
已收盤 12-24 16:00:00 美东时间
3.06
+0.100
+3.38%
華盛通- 最 高3.07
- 今 開2.99
- 成交量 2.41万股
- 最 低 2.9799
- 昨 收 2.96
- 總市值 3886.17万
- 52周最高 3.97
- 市盈率 靜 --
- 換手率 0.19%
- 52周最低 2.66
- 委 比 20.26%
- 總股本 1269.99万
- 歷史最高 8.94
- 量 比 0.17
- 振 幅 3.04%
- 歷史最低 2.37
- 每 手 1
- 風險率 0.18%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Jerash Holdings (US) Sees Q3 Sales $42.108M-$42.816M vs $39.300M Est
Jerash Holdings (US) (NASDAQ:JRSH) sees Q3 sales of $42.108 million-$42.816 million vs $39.300 million analyst estimate.
11-12 21:03
Earnings Scheduled For November 12, 2025
Companies Reporting Before The Bell • Hudbay Minerals (NYSE:HBM) is projected t...
11-12 19:11
Jerash Holdings declares $0.05 dividend
Jerash Holdings (JRSH) declares $0.05/share quarterly dividend, in line with previous. Forward yield 6.19% Payable Nov. 26; for shareholders of record Nov. 19; ex-div Nov. 19. See JRSH Dividend Scorec...
11-07 21:22
Jerash Holdings Re-elects Directors and Approves Compensation
Jerash Holdings (US) ( ($JRSH) ) has issued an announcement. At the annual meet...
09-12 05:28
Jerash Holdings Ends Joint Venture with Newtech
Jerash Holdings (US) ( ($JRSH) ) has shared an announcement. On August 20, 2025...
08-22 04:38
Jerash Holdings (US) Sees Q2 Sales $40.000M-$42.000M vs $40.450M Est
Jerash Holdings (US) (NASDAQ:JRSH) sees Q2 sales of $40.000 million-$42.000 million vs $40.450 million analyst estimate.
08-12 20:04
Earnings Scheduled For August 12, 2025
Companies Reporting Before The Bell • Smithfield Foods (NASDAQ:SFD) is expected...
08-12 16:32
An Overview of Jerash Holdings (US)'s Earnings
Jerash Holdings (US) (NASDAQ:JRSH) will release its quarterly earnings report o...
08-12 01:03
Jerash Holdings declares $0.05 dividend
Jerash Holdings (NASDAQ:JRSH) declared $0.05/share quarterly dividend, in line with previous. Forward yield 6.08% Payable Aug. 29; for shareholders of record Aug. 22; ex-div Aug. 22. See JRSH Dividend...
08-08 20:18
美股大行评级 | 潜在涨幅312.09%！HC Wainwright & Co.上调内克塔治疗目标价至120美元，维持"买入"评级
潜在涨幅312.09%！HC Wainwright & Co.上调内克塔治疗目标价至120美元，维持"买入"评级；联邦快递遭多家机构下调目标价>>
06-26 08:38
